The Society of Hospital Medicine and other studies suggested that a simpler insulin therapy regimen than the basal-bolus might be used initially for T2D individuals with good outpatient glycemic control without insulin therapy or with mild inpatient hyperglycemia ( 26 - 29 ). The gene discussed is INS; the disease is Hyperglycemia.